Delivery Order SPE2DB20D2104-SPE2DB22FS17D
- Not listed
- This federal contract award is for the delivery of Enbrel 50 mg/mL SureClick, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,863.72 firm-fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range...
- This federal contract award is for the delivery of Enbrel 50 mg/mL SureClick medical supplies to the Defense Logistics Agency (DLA). The $43,455.56 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is not designated under any set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in providing a wide range of medical products, including specialty medications,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Enbrel 50 mg/mL SureClick medication. The $14,768 firm-fixed-price delivery order has a completion date of December 12, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for ENBREL 50 MG/ML SURECLICK medication awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $30,494.61 firm fixed-price contract has a completion date of September 27, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,352.40 for the pharmaceutical product ENBREL 50 MG/ML SURECLICK. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on October 27, 2021, with an ultimate completion date of October 28, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of ENBREL 50 MG/ML SURECLICK pharmaceutical products. The firm-fixed-price delivery order, valued at $19,266.88, has a completion date of January 26, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Enbrel 50 mg/mL SureClick medication to the agency. The $8,399.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 22, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Enbrel 50 mg/mL SureClick medication to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,551.54 and runs through May 3, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $20,393.93, is for the delivery of the medication Enbrel 50 mg/mL SureClick and has a completion date of December 8, 2023. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business category. Amerisourcebergen holds two significant Indefinite...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,579.49 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on April 28, 2022, with a completion date of April 29, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS17DDelivery Order
This federal contract award is for the delivery of Enbrel 50 mg/mL SureClick medication, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $32,092.98 firm-fixed-price delivery order has a completion date of March 24, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds several significant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation for the supply of a comprehensive range of pharmaceutical products and medical supplies, valued up to $999,999,999 and $750,000 respectively. These IDCs enable the government to efficiently procure essential medications and healthcare commodities to support military, veterans, and other federal healthcare programs. The contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.1k | 3/23/22 |